Clinical Study
Steroid-Refractory Acute GVHD: Predictors and Outcomes
Table 3
Effect of severity and time of onset of aGVHD on response.
| | Total no. of patients (%) | CR/PR, no. of patients (%) | OR | 95% CI | |
| | Grade I-II and no Hyperacute GVHD | 170 (59) | 110 (65) | Reference | — | — | | Grade I-II and Hyperacute GVHD | 60 (21) | 29 (48) | 0.5 | 0.3–0.9 | 0.03 | | Grade III-IV and no Hyperacute GVHD | 44 (15) | 20 (45) | 0.4 | 0.2–0.9 | 0.02 | | Grade III-IV and Hyperacute GVHD | 13 (5) | 2 (15) | 0.1 | 0.02–0.5 | 0.003 |
|
|
